Propionyl-L-carnitine for intermittent claudication.
- 2021-12-26
- Meta-Analysis · n = 1,395
- The Cochrane database of systematic reviews 2021(12)
- Victor Kamoen
- Robert Vander Stichele
- Laurence Campens
- Dirk De Bacquer
- Luc Van Bortel
- Tine Lm de Backer
- PubMed: 34954832
- DOI: 10.1002/14651858.cd010117.pub2
- High evidence
- Clinical
Mean improvement in ACD was slightly greater for PLC compared to L-carnitine, with a mean difference in absolute improvement of 20.00 meters (95% CI 0.47 to 39.53; 1 study, 14 participants) or a 16% relative improvement (95% CI 0.4% to 31.6%).
- Effect
- Neutral
- Effect size
- Small
- Significant
- Yes
- Dose
- not stated (comparator in single cross-over study)